MGF

Ergogenic / Regenerative

Muscle repair and local adaptation positioning

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Growth-factor peptide
Primary mechanism: IGF-1 splice variant signaling
Primary market use: Sports recovery

Pharmacology

Molecular weight (Da): ~2867
Oral bioavailability: N/A
Half-life: 5 to 7 minutes
Route tags: Route-dependent / verify
Evidence level: Preclinical
Clinical status: Experimental
Value-for-money score: 4 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Durable only if tissue remodeling occurs

Sources

https://pubmed.ncbi.nlm.nih.gov/